Rayner Intraocular Lenses , Ltd.

Rayner Intraocular Lenses, Ltd. specializes in posterior-chamber intraocular lenses (IOLs) for pseudophakic use. These devices are implanted during cataract surgery or lens replacement procedures to restore vision. Their product line includes spherical, aspheric, and injectable acrylic IOLs, such as the RayOne Spheric, 600C Aspheric, and C-flex Aspheric Hydrophilic Acrylic models. The design focuses on improving visual outcomes by mimicking the natural lens’s optical properties.

Rayner Intraocular Lenses, Ltd. is headquartered in the United States. The company’s location influences its regulatory compliance, manufacturing standards, and distribution networks, ensuring its devices meet U.S. standards for medical device authorization.

Rayner Intraocular Lenses, Ltd.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices authorized for use in the U.S., ensuring transparency in the supply chain and regulatory oversight. The UDI system helps healthcare providers and regulators verify device details, such as specifications and compliance status.

Rayner Intraocular Lenses, Ltd.’s intraocular lenses are classified as Class III devices under FDA regulations. This classification applies to devices that support or sustain life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. Due to their critical role in vision restoration, these devices undergo rigorous premarket approval (PMA) or investigational device exemption (IDE) processes to ensure safety and effectiveness before authorization.